<DOC>
	<DOCNO>NCT01000246</DOCNO>
	<brief_summary>Patients treat chemotherapy immunosuppressive high risk influenza infection mortality morbidity high compare healthy adult . Vaccination influenza virus prevent complication . In study investigate whether vaccination chemotherapy effective reach protective serum antibody concentration relation time vaccination ( day 4 +/- 1 day versus day 16 +/- 1 day chemotherapy cycle ) .</brief_summary>
	<brief_title>Response Influenza Virus Vaccination Patients Immunocompromised Due Chemotherapy</brief_title>
	<detailed_description>This study conduct answer question whether vaccination chemotherapy induces adequate antibody response oncology patient . Moreover , effect time vaccination chemotherapy cycle evaluate . In mamma carcinoma patient , effect early versus late vaccination chemotherapy cycle study . It choose vaccinate early group day 4 +/- 1 day ; immediate influence chemotherapy vaccination response expect passed patient already nadir . Late vaccination define vaccination day 16 +/- 1 day cycle . It expect white blood cell platelet count normalise . In order define relatively homogenous patient population mamma carcinoma , study patient recruit treated adjuvant set FEC-containing regimen ( 5-fluorouracil 500 mg/m2 , epirubicin 100 mg/m2 cyclophosphamid 500 mg/m2 ) . The result vaccination immunocompromised group compare serological response vaccination person receive influenza vaccination due heart failure . Studies show , although cytotoxic T-cell response might diminish , rise haemagglutinin inhibition titres patient heart failure vaccinate influenza compare response vaccination otherwise healthy person . These patient heart failure therefore use control group . Patients heart failure treatment immunosuppressive like prednisolone include , prednisolone diminishes response vaccination . The heart failure patient vaccinate accord standard influenza vaccination protocol Netherlands .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients mamma carcinoma treat FECcontaining triweekly chemotherapy moment vaccination Patients heart failure therefore indication influenza vaccination Age ≥ 18 year Signing informed consent Fever time vaccination define temperature ≥ 38.5 °C . Previous/known allergic reaction component vaccine give , example hypersensitivity egg protein Thrombocytopenia ( define &lt; 50 * 109/L ) moment vaccination Treatment prednisolone moment vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>mammacarcinoma</keyword>
	<keyword>breastcancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>heart failure</keyword>
	<keyword>influenza virus vaccine</keyword>
</DOC>